CODX vs RTX
Co-Diagnostics, Inc. Common Stock (CODX) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
CODX currently screens at market cap $31.4M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the CODX and RTX stock pages for the full models.
Not investment advice.